Biotech China 2014

View Profile


Peer Reviewed Papers, Books, Chapters

Year Title Citation Authors
1. 2011 Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mren2.Lewis female rat J Cardiovasc Pharmacol. 2011
2. 2011 Obesity, insulin resistance and diabetes: Sex differences and role of oestrogen receptors. Acta Physiol (Oxf). 2011
3. 2011 Mechanisms of estrogen-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic β cells Endocrinology submitted
4. 2011 Src kinase-arrestin interaction has two independent roles in N-formyl peptide receptor signaling and trafficking In preparation
5. 2011 Induction of interleukin-10 in the t(h)17 effector population by the G protein-coupled estrogen receptor agonist G-1 Immunology. 2011: (submitted).
6. 2011 Full characterization of GPCR monomer-dimer dynamic equilibrium by single molecule imaging. J Cell Biol. 2011, 192: 463-80
7. 2011 GPR30 expression is required for the mineralocorticoid receptor-independent rapid vascular effects of aldosterone Hypertension. 2011
8. 2011 Obesity, insulin resistance and diabetes: Sex differences and role of oestrogen receptors Acta Physiol (Oxf). 2011.
9. 2010 Influence of charge on cell permeability and tumor imaging of GPR30-targeted 111In-labeled non-steroidal imaging agents ACS Chem Biol. 2010, 5: 681-90
10. 2010 Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780 Pharmacology. 2010, 86: 58-64.
11. 2010 Membrane estrogen receptors stimulate intracellular calcium release and progesterone synthesis in hypothalamic astrocytes J Neurosci. 2010, 30: 12950-7.
12. 2010 Co-expression of GPR30 and erbeta and their association with disease progression in uterine carcinosarcoma. Am J Obstet Gynecol. 2010, 203: 242.e1-.e5.
13. 2010 Insulin-like growth factor 2 expression modulates taxol resistance and is a candidate biomarker for reduced disease-free survival in ovarian cancer Clin Cancer Res. 2010.
14. 2010 Highly efficient synthesis and characterization of the GPR30-selective agonist G-1 and related tetrahydroquinoline analogs. Org Biolmol Chem. 2010, 8: 2252-9.
15. 2010 Expression of G protein-coupled receptor 30 in the spinal somatosensory system Brain Res. 2010, 1310: 17-28.
16. 2010 GPR30 and estrogen receptor expression: New insights into hormone dependence of inflammatory breast cancer Breast Cancer Res Treat. 2010, 123: 51-8.
17. 2010 The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells Cancer Res. 2010, 70: 1184-94
18. 2010 Lung cancer and hormone replacement therapy Lancet. 2010, 375: 117-8; author reply 8-9
19. 2010 Synthesis and characterization of iodinated tetrahydroquinolines targeting the G protein-coupled estrogen receptor GPR30 J Med Chem. 2010, 53: 1004-14.
20. 2009 Localisation of GPR30, a novel G protein-coupled oestrogen receptor, suggests multiple functions in rodent brain and peripheral tissues J Endocrinol. 2009, 202: 223-36
21. 2009 Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER Prostaglandins Other Lipid Mediat
22. 2009 Mechanisms of estrogen signaling and gene expression via GPR30 Mol Cell Endocrinol
23. 2009 Non-genomic signaling by steroids Mol Cell Endocrinol
24. 2009 Guide to receptors and channels (grac), 4th edition: Gpe receptor Br J Pharmacol. 2009, 1: S000
25. 2009 Non-genomic regulation of vascular cell function and growth by estrogen Mol Cell Endocrinol. 2009, 308: 9-16
26. 2009 High-content screening: Flow cytometry analysis Methods Mol Biol. 2009, 486: 151-65
27. 2009 Detection of intracellular granularity induction in prostate cancer cell lines by small molecules using the hypercyt high-throughput flow cytometry system J Biomol Screen. 2009, 14: 596-609.
28. 2009 Non-genomic regulation of vascular cell function and growth by estrogen. Mol Cell Endocrinol. 2009, 308: 9-16
29. 2009 Guide to receptors and channels (grac) 4th edition: Gpe receptor. Br J Pharmacol. 2009, 1: S000.
30. 2009 GPER (G protein-coupled estrogen receptor 1) Atlas Genet Cytogenet Oncol Haematol
31. 2009 Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER. Prostaglandins Other Lipid Mediat. 2009: 89-97.
32. 2009 Mechanisms of estrogen signaling and gene expression via GPR30 Mol Cell Endocrinol. 2009, 308: 32-8.
33. 2009 Non-genomic signaling by steroids Mol Cell Endocrinol. 2009, 308: 1-2
34. 2009 GPR30 predicts poor survival for ovarian cancer Gynecol Oncol. 2009, 114: 465-71.
35. 2009 A novel fluorescent cross-reactive formylpeptide receptor/formylpeptide receptor-like 1 hexapeptide ligand Cytometry A. 2009, 75: 264-70
36. 2009 Adaptor protein-2 interaction with arrestin regulates GPCR recycling and apoptosis Traffic. 2009, 10: 1286-300
37. 2009 Extra-nuclear estrogen receptor GPR30 regulates serotonin function in rat hypothalamus Neuroscience. 2009, 158: 1599-607.
38. 2009 Duplex high-throughput flow cytometry screen identifies two novel formylpeptide receptor family probes. Cytometry A. 2009, 75: 253-63
39. 2009 Estrogen and progesterone receptor status and outcome of epithelial ovarian cancer Gynecol Oncol. 2009, 114: 480-5
40. 2009 Discovery of selective probes and antagonists for G-protein-coupled receptors fpr/fprl1 and GPR30 Curr Top Med Chem. 2009, 9: 1227-36.
41. 2009 Beneficial role of the GPR30 agonist G-1 in an animal model of multiple sclerosis J Neuroimmunol. 2009, 214: 67-77
42. 2009 In vivo effects of a GPR30 antagonist Nat Chem Biol. 2009, 5: 421-7
43. 2009 Expression of estrogen receptor GPR30 in the rat spinal cord and in autonomic and sensory ganglia J Neurosci Res. 2009, 87: 1610-9.
44. 2009 High-content screening: Flow cytometry analysis. Methods Mol Biol. 2009, 486: 151-65
45. 2009 Effect of dota position on melanoma targeting and pharmacokinetic properties of 111In-labeled lactam bridge-cyclized alpha-melanocyte stimulating hormone peptide Bioconjug Chem. 2009, 20: 2162-8.
46. 2009 Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity Best Manuscript Award. Circul Res. 2009, 104: 288-91.
47. 2008 Pre-clinical development of a neutral, estrogen receptor-targeted, tridentate 99mtc(i) estradiol pyridin-2-yl hydrazine derivative for imaging of breast and endometrial cancers J Nuc Med. 2008, 49: 978-86.
48. 2008 Estrogen action via the transmembrane receptor GPR30 Annu Rev Physiol. 2008, 70: 165-90.
49. 2008 The ins and outs of GPR30: A transmembrane estrogen receptor J Steroid Biochem Mol Biol. 2008, 109: 350-3
50. 2008 . GPR30: A novel therapeutic target in estrogen-related disease. Trends Pharmacol Sci. 2008, 29: 116-23
51. 2008 The G protein-coupled receptor GPR30 inhibits human urothelial cell proliferation. Endocrinology. 2008, 149: 4024-34
52. 2008 G protein-coupled receptor 30 expression is required for estrogen stimulation of primordial follicle formation in the hamster ovary. Endocrinology. 2008, 149: 4452-61
53. 2008 GPR30: a novel therapeutic target in estrogen-related disease Trends Pharmacol. Sci. 29, 116-123
54. 2008 Estrogen action via the transmembrane receptor GPR30 Annu Rev Physiol 70, 165-190
55. 2008 G protein-coupled receptor 30 and estrogen receptor alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells Environ Health Perspective. 2008, doi:10.1289/ehp.11297
56. 2008 Enhancement of somatostatin-receptor-targeted (177)lu-[dota(0)-tyr(3)]-octreotide therapy by gemcitabine pretreatment-mediated receptor uptake, up-regulation and cell cycle modulation Nucl Med Biol. 2008, 35: 673-8.
57. 2008 A multifunctional androgen receptor screening assay using the high-throughput hypercyt flow cytometry system Cytometry A. 2008, 73: 390-9
58. 2008 Expression and intracellular distribution of the G protein-coupled receptor 30 in rat hippocampal formation Neurosci Lett. 2008, 441: 94-9.
59. 2007 Distribution and characterization of estrogen receptor G protein-coupled receptor 30 in the rat central nervous system. J Endocrinol. 2007, 193: 311-21
60. 2007 G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res. 2007, 67: 1859-66
61. 2007 Some mechanistic insights into GPCR activation from detergent-solubilized ternary complexes on beads Advances in Protein Chemistry2007. p. 95-135.
62. 2007 Somatostatin-receptor-targeted alpha-emitting 213bi is therapeutically more effective than beta(-)-emitting 177Lu in human pancreatic adenocarcinoma cells Nucl Med Biol. 2007, 34: 185-93
63. 2007 GPR30: A G protein-coupled receptor for estrogen Mol Cell Endocrinol. 2007, 265-266: 138-42.
64. 2007 Modulation of GPCR conformations by ligands, G proteins and arrestins In: Bourne H, Horuk R, Kuhnke J, Michel H, editors. GPCRs: From deorphanization to lead structure identification2007. p. 211-28
65. 2007 Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30 ACS Chem Biol. 2007, 2: 536-44.
66. 2007 Expression of GPR30, a G protein-coupled membrane estrogen receptor, in oxytocin neurons of the rat paraventricular and suproptic nuclei Endocrinology. 2007, 148: 5842-50.
67. 2007 GPR30: A novel indicator of poor survival for endometrial carcinoma Am J Obstet Gynecol. 2007, 196: 386 e1-9; discussion e9-11.
68. 2007 Expression of GPR30 in the hamster ovary: Differential regulation by gonadotropins and steroids hormones Endocrinology. 2007, 148: 4853-64
69. 2007 Rapid-mix flow cytometry measurements of subsecond regulation of G protein-coupled receptor ternary complex dynamics by guanine nucleotides Anal Biochem. 2007, 371: 10-20.
70. 2007 Activated N-formyl peptide receptor and high-affinity IgE receptor occupy common domains for signaling and internalization. Mol Biol Cell. 2007, 18: 1410-20
71. 2007 GPR30: A G protein-coupled receptor for estrogen Mol Cell Endocrinol 265-266, 138-42
72. 2006 Steroid-binding G-protein-coupled receptors: new drug discovery targets for old ligands? Expert Opinion on Drug Discovery 1, 137-150.
73. 2006 Regulation of N-formyl peptide receptor signaling and trafficking by individual carboxyl-terminal serine and threonine residues J Immunol. 2006, 176: 5418-25.
74. 2006 GPR30. UCSD-Nature Molecule Pages. 2006: doi:10.1038/mp.a003779.01.
75. 2006 Steroid-binding G-protein-coupled receptors: New drug discovery targets for old ligands? Expert Opinion on Drug Discovery. 2006, 1: 137-50
76. 2006 Linkage effects on binding affinity and activation of GPR30 and estrogen receptors ERalpha/beta with tridentate pyridin-2-yl hydrazine tricarbonyl-Re/(99m)Tc(I) chelates. J Am Chem Soc. 2006, 128: 14476-7
77. 2006 Glutathione-s-transferase-green fluorescent protein fusion protein reveals slow dissociation from high site density beads and measures free gsh Cytometry A. 2006, 69A: 326-34.
78. 2006 Biomolecular screening of formylpeptide receptor ligands with a sensitive, quantitative, high-throughput flow cytometry platform. Nat Protoc 1, 59-66.
79. 2006 Virtual and biomolecular screening converge on a selective agonist for GPR30. Faculty of 1000 biology. Nat Chem Biol. 2006, 2: 207-12.
80. 2006 Biomolecular screening of formylpeptide receptor ligands with a sensitive, quantitative, high-throughput flow cytometry platform Nat Protoc. 2006, 1: 59-66
81. 2006 G protein-coupled receptors serve as mechanosensors for fluid shear stress in neutrophils. Am J Physiol Cell Physiol. 2006, 290: C1633-9.
82. 2006 Screening for caspase-3 inhibitors: A new class of potent small-molecule inhibitors of caspase-3. J Biomol Screen. 2006, 11: 277-85
83. 2005 High-throughput screening with hypercyt flow cytometry to detect small molecule formylpeptide receptor ligands J Biomol Screen. 2005, 10: 374-82
84. 2005 Integration of virtual screening with high throughput flow cytometry to identify novel small molecule formylpeptide receptor antagonists Mol Pharmacol. 2005, 68: 1301-10
85. 2005 Inhibition of chemoattractant N-formyl peptide receptor trafficking by active arrestins. Traffic. 2005, 6: 87-99.
86. 2005 Post-high-throughput screening analysis: An empirical compound prioritization scheme J Biomol Screen. 2005, 10: 419-26
87. 2005 strogen receptors and cell signaling - response. Science. 2005, 310: 52-3
88. 2005 Conformational differences between arrestin2 and pre-activated mutants as revealed by hydrogen exchange mass spectrometry J Mol Biol. 2005, 351: 865-78.
89. 2005 A transmembrane intracellular estrogen receptor mediates rapid cell signaling Science. 2005, 307: 1625-30
90. 2004 Arrestins block G protein-coupled receptor-mediated apoptosis. J Biol Chem. 2004, 279: 24578-84.
91. 2004 Flow cytometry for high-throughput, high-content screening. Curr Opin Chem Biol 8, 392-8
92. 2004 Mechanisms of G protein-coupled receptor-mediated degranulation FEMS Microbiol Lett 236, 1-6
93. 2004 echniques: GPCR assembly, pharmacology and screening by flow cytometry Trends Pharmacol Sci 25, 663-9
94. 2004 High-throughput microfluidic mixing and multiparametric cell sorting for bioactive compound screening J Biomol Screen. 2004, 9: 103-11.
95. 2004 N-formyl peptide receptors cluster in an active raft-associated state prior to phosphorylation. J Biol Chem. 2004, 279: 45175-84
96. 2004 Techniques: GPCR assembly, pharmacology and screening by flow cytometry Trends Pharmacol Sci. 2004, 25: 663-9
97. 2004 Mechanisms of G protein-coupled receptor-mediated degranulation FEMS Microbiol Lett. 2004, 236: 1-6.
98. 2004 Real-time analysis of ternary complex on particles: Direct evidence for partial agonism at the agonist-receptor-G protein complex assembly step of signal transduction J Biol Chem. 2004, 279: 13514-21.
99. 2004 Chemotactic peptide/complement receptors In: Lennarz WJ, Lane MD, editors. Encyclopedia of biological chemistry. San Diego CA: Elsevier Science; 2004. p. 425-9
100. 2004 Novel roles for arrestins in the post-endocytic trafficking of G protein-coupled receptors Life Sci. 2004, 75: 893-9.
101. 2004 Chemotaxis inhibitory protein of staphylococcus aureus binds specifically to the c5a and formylated peptide receptor J Immunol. 2004, 172: 6994-7001
102. 2004 Flow cytometry for high-throughput, high-content screening. Curr Opin Chem Biol. 2004, 8: 392-8.
103. 2004 Conformational regulation of alpha 4 beta 1-integrin affinity by reducing agents. "Inside-out" Signaling is independent of and additive to reduction-regulated integrin activation. J Biol Chem. 2004, 279: 32435-43.
104. 2003 N-formyl peptide receptor phosphorylation domains differentially regulate arrestin and agonist affinity J Biol Chem. 2003, 278: 4041-7.
105. 2003 Chemokines and chemokine receptors IDrugs. 2003, 6: 191-4.
106. 2003 Functional capabilities of an N-formyl peptide receptor-G(alpha)(i)(2) fusion protein: Assemblies with G proteins and arrestins Biochemistry. 2003, 42: 7283-93.
107. 2003 Ligand-receptor-G-protein molecular assemblies on beads for mechanistic studies and screening by flow cytometry Mol Pharmacol. 2003, 64: 1227-38
108. 2003 N-formyl peptide receptors internalize but do not recycle in the absence of arrestins J Biol Chem. 2003, 278: 41581-4
109. 2003 Chemokines and chemokine receptors IDrugs 6, 191-4.
110. 2003 High throughput screening of G-protein coupled receptors via flow cytometry. Comb Chem High Throughput Screen. 2003, 6: 389-97
111. 2003 Fret detection of cellular alpha4-integrin conformational activation Biophys J. 2003, 85: 3951-62
112. 2003 Alpha4beta1 integrin affinity changes govern cell adhesion J Biol Chem. 2003, 278: 38174-82
113. 2002 Performance of in-line microfluidic mixers in laminar flow for high-throughput flow cytometry BioTechniques. 2002, 33: 220-6.
114. 2002 Arrestin variants display differential binding characteristics for the phosphorylated N-formyl peptide receptor carboxyl terminus J Biol Chem. 2002, 277: 8970-8
115. 2002 Flow cytometric analysis of ligand-receptor interactions and molecular assemblies Annu Rev Biophys Biomol Struct. 2002, 31: 97-119
116. 2002 Flow cytometric analysis of ligand-receptor interactions and molecular assemblies Annu Rev Biophys Biomol Struct 31, 97-119.
117. 2002 Regulation of N-formyl peptide-mediated degranulation by receptor phosphorylation J Immunol. 2002, 169: 6760-6
118. 2002 Dexras1/ags-1 inhibits signal transduction from the gi-coupled formyl peptide receptor to erk-1/2 map kinases J Biol Chem. 2002, 277: 10876-82.
119. 2001 Real-time analysis of G protein-coupled receptor reconstitution in a solubilized system. J Biol Chem. 2001, 276: 22453-60
120. 2001 Real time analysis of the affinity regulation of alpha 4-integrin. The physiologically activated receptor is intermediate in affinity between resting and mn(2+) or antibody activation J Biol Chem. 2001, 276: 48670-8
121. 2001 Plug flow cytometry extends analytical capabilities in cell adhesion and receptor pharmacology. Cytometry. 2001, 43: 211-6.
122. 2001 Htps flow cytometry: A novel platform for automated high throughput drug discovery and characterization J Biomol Screen. 2001, 6: 83-90.
123. 2001 Internalization of the human N-formyl peptide and c5a chemoattractant receptors occurs via clathrin-independent mechanisms Biochemistry. 2001, 40: 3467-75
124. 2001 Regulation of formyl peptide receptor agonist affinity by reconstitution with arrestins and heterotrimeric G proteins J Biol Chem. 2001, 276: 49204-12.
125. 2001 Partial phosphorylation of the N-formyl peptide receptor inhibits G protein association independent of arrestin binding J Biol Chem. 2001, 276: 49195-203.
126. 2000 Arrestin binding to the G protein-coupled N-formyl peptide receptor is regulated by the conserved "Dry" Sequence J Biol Chem. 2000, 275: 24590-4.
127. 2000 Analysis of free intracellular calcium by flow cytometry: Multiparameter and pharmacologic applications Methods. 2000, 21: 221-30.
128. 2000 Deficient homologous desensitization of formyl peptide receptors stably expressed in undifferentiated hl-60 cells Biochem Pharmacol. 2000, 60: 179-87
129. 2000 Solubilization and display of G protein-coupled receptors on beads for real-time fluorescence and flow cytometric analysis BioTechniques. 2000, 28: 976-80, 82-5
130. 1999 Differential phosphorylation paradigms dictate desensitization and internalization of the N-formyl peptide receptor J Biol Chem. 1999, 274: 29791-5
131. 1999 Flow cytometry: A versatile tool for all phases of drug discovery. Drug Discov Today. 1999, 4: 173-80
132. 1999 Multiple activation steps of the N-formyl peptide receptor Biochemistry. 1999, 38: 2240-7
133. 1999 Flow cytometry: a versatile tool for all phases of drug discovery Drug Discov Today 4, 173-180.
134. 1999 The uncoupled state of the human formyl peptide receptor J Recept Signal Transduct Res. 1999, 19: 327-40
135. 1998 Activation of mitogen-activated protein kinases by formyl peptide receptors is regulated by the cytoplasmic tail J Biol Chem. 1998, 273: 20916-23.
136. 1998 Strategies for positioning fluorescent probes and crosslinkers on formyl peptide ligands J Recept Signal Transduct Res. 1998, 18: 187-221.
137. 1997 Cell type- and developmental stage-specific activation of nf-kappab by fmet-leu-phe in myeloid cells J Biol Chem. 1997, 272: 7995-8001
138. 1997 The N-formyl peptide receptor: a model for the study of chemoattractant receptor structure and function Pharmacol Ther 74, 73-102
139. 1997 Phosphorylation of the N-formyl peptide receptor is required for receptor internalization but not chemotaxis J Biol Chem. 1997, 272: 29426-9
140. 1997 Cloning and functional characterization of the mouse c3a anaphylatoxin receptor gene Immunogenetics. 1997, 47: 64-72
141. 1997 Undifferentiated u937 cells transfected with chemoattractant receptors: A model system to investigate chemotactic mechanisms and receptor structure/function relationships. J Leukoc Biol. 1997, 61: 329-37
142. 1997 Desensitization of n-formylpeptide receptor-mediated activation is dependent upon receptor phosphorylation J Biol Chem. 1997, 272: 15213-9
143. 1997 The N-formyl peptide receptor: A model for the study of chemoattractant receptor structure and function Pharmacol Ther. 1997, 74: 73-102.
144. 1997 Identification of an N-formyl peptide receptor ligand binding domain by a gain-of-function approach Biochem Biophys Res Commun. 1997, 238: 377-81
145. 1996 Gene transcription through activation of G-protein-coupled chemoattractant receptors. Gene Expr. 1996, 5: 205-15.
146. 1996 cDNA cloning of a novel G protein-coupled receptor with a large extracellular loop structure Biochim Biophys Acta. 1996, 1305: 39-43
147. 1996 A tyrosine kinase signaling pathway accounts for the majority of phosphatidylinositol 3,4,5-trisphosphate formation in chemoattractant-stimulated human neutrophils. J Biol Chem. 1996, 271: 25204-7
148. 1996 Bradykinin stimulates nf-kappab activation and interleukin 1beta gene expression in cultured human fibroblasts J Clin Invest. 1996, 98: 2042-9
149. 1995 Phosphorylation of the N-formyl peptide receptor carboxyl terminus by the G protein-coupled receptor kinase, grk2 J Biol Chem. 1995, 270: 1130-7.
150. 1995 Investigation of neutrophil signal transduction using a specific inhibitor of phosphatidylinositol 3-kinase J Immunol. 1995, 154: 2413-22.
151. 1995 Binding of low affinity N-formyl peptide receptors to G protein. Characterization of a novel inactive receptor intermediate J Biol Chem. 1995, 270: 10686-94.
152. 1994 Domains of the human neutrophil N-formyl peptide receptor involved in G protein coupling. Mapping with receptor-derived peptides J Biol Chem. 1994, 269: 326-31.
153. 1993 Reconstitution of recombinant N-formyl chemotactic peptide receptor with G protein J Leukoc Biol. 1993, 53: 470-4
154. 1993 The rabbit neutrophil N-formyl peptide receptor. cDNA cloning, expression, and structure/function implications. J Immunol. 1993, 150: 1383-94.
155. 1993 Absence of G(i) proteins in the sf9 insect cell. Characterization of the uncoupled recombinant N-formyl peptide receptor. J Biol Chem. 1992, 267: 19757-60.
156. 1993 Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding. Construction and analysis of chimeric N-formyl peptide receptors J Biol Chem. 1993, 268: 18167-75
157. 1993 Signal transducing properties of the N-formyl peptide receptor expressed in undifferentiated hl60 cells. J Immunol. 1993, 151: 5704-15
158. 1993 The role of the third intracellular loop of the neutrophil N-formyl peptide receptor in G protein coupling Biochem J. 1993, 294 ( Pt 2): 581-7.
159. 1992 Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor Biochem Biophys Res Commun. 1992, 184: 582-9
160. 1991 Determination of a region of the hisj binding protein involved in the recognition of the membrane complex of the histidine transport system of salmonella typhimurium J Biol Chem. 1991, 266: 9673-7.
161. 1991 Transmembrane signalling by the N-formyl peptide receptor in stably transfected fibroblasts Biochem Biophys Res Commun. 1991, 179: 471-6
162. 1991 Characterization of a human cDNA that encodes a functional receptor for platelet activating factor. Biochem Biophys Res Commun. 1991, 180: 105-11
163. 1989 Reconstitution of the histidine periplasmic transport system in membrane vesicles. Energy coupling and interaction between the binding protein and the membrane complex. J Biol Chem. 1989, 264: 5006-14
164. 1988 Role of the intercistronic region in post-transcriptional control of gene expression in the histidine transport operon of salmonella typhimurium: Involvement of rep sequences Mol Microbiol. 1988, 2: 141-52
165. 1988 Formaldehyde and photoactivatable cross-linking of the periplasmic binding protein to a membrane component of the histidine transport system of salmonella typhimurium. J Biol Chem. 1988, 263: 17917-20


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.